CAPSOVISION INC (CV)
Health Care · Capsule endoscopy and GI diagnostic imaging · NASDAQ
CapsoVision commercializes AI-powered capsule endoscopy systems with panoramic imaging for small bowel and emerging colon diagnostics, targeting gastroenterologists globally.
What CAPSOVISION INC does
CapsoVision is a global medical technology company that develops and commercializes capsule endoscopy solutions for visualizing and diagnosing abnormalities of the GI tract. The company's core product, CapsoCam Plus, is a single-use capsule endoscope with panoramic imaging for small bowel visualization, supported by cloud-based software (CapsoCloud and CapsoView) and AI-assisted pathology detection tools. CapsoVision is expanding its portfolio with CapsoCam Colon, a next-generation capsule incorporating 3D sensing for polyp detection and measurement, currently in late-stage FDA review.
Themes: ["capsule endoscopy / GI diagnostics","AI-assisted pathology detection","cloud-based medical imaging","colorectal polyp detection","small bowel visualization","pancreatic cancer screening"]
Fundamentals
- Price$5.77 as of 2026-07-09 close
- Market cap$288M as of 2026-07-10
- 1-year return+18.0% as of 2026-07-09 close
- Net margin-198.9% as of 2026-07-10
- Gross margin+51.7% as of 2026-07-10
- ROE-184.2% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)+0.3% as of 2026-07-10
- Beta-1.64 as of 2026-07-10
Key risks (from latest filing)
["Dependence on FDA clearances for pipeline products (CapsoCam Colon and AI-enhanced CapsoCam Plus); regulatory delays or denials could materially impact growth and commercialization timelines.","Significant operating losses and negative net margins (-198.87%) with minimal revenue growth (0.32% YoY); company is unprofitable and dependent on capital to fund R&D and commercialization efforts.","Supply chain concentration risk; manufacturing relies on component suppliers and assembly partners in Asia (Taiwan and Japan), creating exposure to geopolitical disruption and supply constraints."]
Competitors & peers
- Intromedic (pillcam/capsule endoscopy)
- Boston Scientific (capsule endoscopy / GI diagnostics)
- Medtronic (endoscopy and GI diagnostics)
- Pentax Medical (endoscopy systems)
- Olympus (endoscopy and medical imaging)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.